Compile Data Set for Download or QSAR
maximum 50k data
Found 112 of ec50 for UniProtKB: P03420
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554856(CHEMBL4740044)
Affinity DataEC50:  0.270nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554858(CHEMBL4750881)
Affinity DataEC50:  0.330nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554876(CHEMBL4747540)
Affinity DataEC50:  0.470nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554877(CHEMBL4755451)
Affinity DataEC50:  0.640nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554856(CHEMBL4740044)
Affinity DataEC50:  0.700nMAssay Description:Inhibition of F protein D486N mutant in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554874(CHEMBL4746199)
Affinity DataEC50:  0.740nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554875(CHEMBL4765002)
Affinity DataEC50:  0.770nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554864(CHEMBL4747375)
Affinity DataEC50:  0.810nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554859(CHEMBL4747256)
Affinity DataEC50:  0.870nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554872(CHEMBL4751254)
Affinity DataEC50:  1.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554873(CHEMBL4752524)
Affinity DataEC50:  1.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554866(CHEMBL4753413)
Affinity DataEC50:  1.40nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554867(CHEMBL4752460)
Affinity DataEC50:  1.40nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554860(CHEMBL4757367)
Affinity DataEC50:  1.70nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50541848(CHEMBL4640616)
Affinity DataEC50:  2nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554861(CHEMBL4779491)
Affinity DataEC50:  2.10nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554870(CHEMBL4742185)
Affinity DataEC50:  2.5nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554863(CHEMBL4741045)
Affinity DataEC50:  2.70nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554858(CHEMBL4750881)
Affinity DataEC50:  3.10nMAssay Description:Inhibition of F protein D486N mutant in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554865(CHEMBL4761881)
Affinity DataEC50:  4.60nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554862(CHEMBL4758615)
Affinity DataEC50:  7nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50541848(CHEMBL4640616)
Affinity DataEC50:  8.10nMAssay Description:Inhibition of Human respiratory syncytial virus Fusion protein D486N mutant expressed in Hep2 cells assessed as reduction in virus-induced cytopathic...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534230(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  11nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534252(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  13nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554871(CHEMBL4756466)
Affinity DataEC50:  17nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534272(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  17nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554857(CHEMBL4752948)
Affinity DataEC50:  17nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534244(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  17nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534248(WO2022081973, Example 52)
Affinity DataEC50:  17nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554869(CHEMBL4782630)
Affinity DataEC50:  21nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534245(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  23nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534271(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  24nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534251(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  24nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534246(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  24nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534249(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  25nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534242(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  26nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534243(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  32nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534228(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  40nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534207(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  47nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534201(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  50nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534210(2-(((2R)-1-(((((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1...)
Affinity DataEC50:  53nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554868(CHEMBL4746117)
Affinity DataEC50:  54nMAssay Description:Inhibition of F protein in Respiratory syncytial virus A2 infected in HepG2 cells assessed as reduction in virus-induced cytopathic effect incubated ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534206(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  55nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534270(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  58nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534239(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  59nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534237(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  63nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534246(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  64nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534268(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  68nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534214(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  69nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetFusion glycoprotein F0(Human respiratory syncytial virus A (strain A2))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM534225(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]tria...)
Affinity DataEC50:  70nMAssay Description:Antiviral activity of compounds against SARS-CoV-2 is evaluated as described in Xue, Xi et al.2020. Briefly, the human alveolar epithelial cell line ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 112 total ) | Next | Last >>
Jump to: